This document is a short account of a speech by the laboratory supervisor from a trial in Liberia of the new antimalarial drug combination ASAQ (artesunate + amodiaquine). It was found that good-quality research studies could be implemented in remote areas provided some main requirements were met; these can be summarized under the headings of technical capacity building (training and equipment) and establishment of institutional memory. Information on how this was done in the study under discussion is provided. It was also concluded that locally appropriate normal values for test results are needed.
Presentation from DNDi’s 2nd Stakeholders’ Meeting & 3rd African Meeting, Nairobi, Kenya, 23 June 2009.